This Week in Cannabis News – Feb 21 to Feb 27 2022

* news is NOT investment advice. It’s for educational purposes only.*
Mid- Update: 8
Trulieve & Verano Q3: U
Curaleaf Q3: M
Green Thumb, Cresco, Columbia Care Q3: A

Direct to Pelosi to Support #SAFE: t

Timecodes:
00:00 – Intro
00:40 – 428,059 Americans Work in Industry as of 2021, Still Not Counted in BLS
2:32 – MI Industry Sees 72% Increase as 3rd Most Canna Related Jobs in Country
3:06 – CA Reported $308M in Quarterly Tax Revenue via Todd Harrison
4:00 – Sales Increased Across WA to $1.5B in 2021, Soaring Sales in Rural Areas
5:37 – OH topped $381M in Medical Sales in 2021, a 72% Increase From 2020
6:05 – FL Adds 3,427 Patients, Strong Sales
6:53 – NJ Update – Governor Says Legal Sales Could Start Within Weeks Through Medical
8:45 – CRC Fails to Launch at 24th Meeting But Paves Way for THC Concentrates
9:35 – South Dakota Senate Approves Legalization + Expungement Bills, Moves to House
10:52 – MD House Approves Bills to Put Legalization on 2022 Ballot & Set Rules For Nov
12:03 – NM Medical Firm Wins in Court Decision, State Department’s Appeal Denied
12:53 – NCAA Makes Small Changes, Easing Canna Rules. Why Still Testing Anyways?
13:58 – Snapshot of Benefits (Left) & Risks (Right) Of Medical Cannabis via @Rdeevoy
14:24 – Study Finds CBD Protects Against Alzheimer’s, Can We Deschedule Yet?
15:01 – Flower Associated with Symptom Improvements in ADHD, Small Patient Sample
16:01 – Recording of Boris Jordan & MJ Stocktrader Twitter Spaces, Worth a Listen!
16:29 – Visual Capitalist Part 3 – Guide to US Cannabis
16:43 – MSO Earnings Start , GTI on Tuesday, Curaleaf on Thursday

Sources:
/

f

s

6

/

1

f

l

/

/

/

/

/>
3

5

/

7

/

/

This Week in Cannabis is a weekly recap of the Cannabis industry for retail investors to learn about the budding opportunity unfolding in North America before Cannabis goes global.

Disclaimer
**This is not investment advice. It’s educational entertainment to help investors learn about the US Cannabis Industry. Invest at your risk. **

You May Also Like

Leave a Reply

Your email address will not be published.